title: Fulminant progression of hyperammonaemic encephalopathy after treatment with valproate in a patient with ureterosigmoidostomy.
authors.forename: S
authors.initials: S
authors.lastname: Schwarz
authors.forename: D
authors.initials: D
authors.lastname: Georgiadis
authors.forename: S
authors.initials: S
authors.lastname: Schwab
authors.forename: F
authors.initials: F
authors.lastname: Gehlen
authors.forename: E
authors.initials: E
authors.lastname: Mayatepek
authors.forename: S
authors.initials: S
authors.lastname: Zoubaa
mesh_terms: D000328:Adult; D000641:Ammonia / Q000378:metabolism*; D000714:Anastomosis, Surgical; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D001928:Brain Diseases, Metabolic / Q000175:diagnosis* / Q000209:etiology / Q000378:metabolism; D012809:Colon, Sigmoid / Q000378:metabolism / Q000601:surgery; D017809:Fatal Outcome; D006801:Humans; D022124:Hyperammonemia / Q000150:complications* / Q000175:diagnosis* / Q000209:etiology / Q000378:metabolism; D007408:Intestinal Absorption; D008297:Male; D014547:Urinary Diversion / Q000009:adverse effects* / Q000379:methods; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000927:Anticonvulsants; D014635:Valproic Acid; D000641:Ammonia